In conversation with Krishna Raghunathan, CFO of Supriya Lifescience Ltd
In conversation with Krishna Raghunathan, CFO of Supriya Lifescience Ltd
Today's customers are more informed, and regulatory expectations for quality are higher than ever. Given these factors, I believe the Indian pharmaceutical industry is set for continued growth and global leadership, states Krishna Raghunathan, CFO of Supriya Lifescience Ltd.
Today's customers are more informed, and regulatory expectations for quality are higher than ever. Given these factors, I believe the Indian pharmaceutical industry is set for continued growth and global leadership, states Krishna Raghunathan, CFO of Supriya Lifescience Ltd.
Is your portfolio bleeding again? Here’s the reason!
This situation echoes the economic challenges of the 1970s and suggests that investors should brace for potential market volatility.
This situation echoes the economic challenges of the 1970s and suggests that investors should brace for potential market volatility.
Promoters buy 10,000 shares in this small-cap company, stock rebounds from day’s low: Do you own it?
The stock remains around 25 per cent below its 52-week high of Rs 511 on the BSE, indicating potential upside if market sentiment improves.
The stock remains around 25 per cent below its 52-week high of Rs 511 on the BSE, indicating potential upside if market sentiment improves.
In conversation with Arul Selvan, President and CFO of Cholamandalam Investment and Finance Company Limited
Cholamandalam Investment and Finance Company Limited is not only on an expanding spree, both geographically and with the introduction of new product lines, but is also leveraging technology to improve its functioning across the country. Excerpts from an interview with the company’s President and CFO Arul Selvan
Cholamandalam Investment and Finance Company Limited is not only on an expanding spree, both geographically and with the introduction of new product lines, but is also leveraging technology to improve its functioning across the country. Excerpts from an interview with the company’s President and CFO Arul Selvan
Gold hits record highs: Are gold stocks the next big opportunity?
Here’s a list of gold stocks that are down up to 60 per cent from their 52-week highs—but are they worth investing in? Find out here!
Here’s a list of gold stocks that are down up to 60 per cent from their 52-week highs—but are they worth investing in? Find out here!
Investing in a falling market? This key factor helps you pick resilient stocks!
Companies with 'this advantage' not only withstand downturns but also emerge more resilient, ensuring stability and promising long-term growth.
Companies with 'this advantage' not only withstand downturns but also emerge more resilient, ensuring stability and promising long-term growth.
Investing in the future: A high-voltage IPO in the power sector!
The ongoing expansion of India’s energy sector, coupled with the global shift towards renewable energy, along with the company's comprehensive product portfolio and robust financial track record, strategically positions it for long-term growth.
The ongoing expansion of India’s energy sector, coupled with the global shift towards renewable energy, along with the company's comprehensive product portfolio and robust financial track record, strategically positions it for long-term growth.
In conversation with Rajesh Jain, CFO of RR Kabel Limited
India's cables and wires industry is poised for strong growth, driven by increasing infrastructure investments, rising urbanisation, and the push towards smart and energy-efficient electrical solutions, states Rajesh Jain, CFO of RR Kabel Limited.
India's cables and wires industry is poised for strong growth, driven by increasing infrastructure investments, rising urbanisation, and the push towards smart and energy-efficient electrical solutions, states Rajesh Jain, CFO of RR Kabel Limited.
Artificial intelligence (AI) at the core: Is this IPO worth your investment?
Between CY21 and CY23, the company has achieved a Compound Annual Growth Rate (CAGR) of 20 per cent in revenue and 15 per cent in net profit.
Between CY21 and CY23, the company has achieved a Compound Annual Growth Rate (CAGR) of 20 per cent in revenue and 15 per cent in net profit.
IPO Alert: Debt-free company with 77 per cent market share in SLCMs; should you subscribe?
Between FY22 and FY24, it achieved a Compound Annual Growth Rate (CAGR) of 52 per cent in revenue and 85 per cent in net profit.
Between FY22 and FY24, it achieved a Compound Annual Growth Rate (CAGR) of 52 per cent in revenue and 85 per cent in net profit.
Union Budget 2025: Strengthening Agriculture & Rural Growth
Discover how the Union Budget 2025 outlines ambitious strategies to drive growth in the agricultural sector.
Discover how the Union Budget 2025 outlines ambitious strategies to drive growth in the agricultural sector.
Why investors should blink twice before investing in this IPO: Have a look!
The company held a market share of approximately 25 per cent in the organised eye care service chain business in India during FY24.
The company held a market share of approximately 25 per cent in the organised eye care service chain business in India during FY24.